Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Pramipexole ER in Advanced Parkinson's Disease
NCT00577460Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Dec 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00577460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577460.